Embolism Clinical Trial
Official title:
Clinical Significance of Retinal Emboli During Diagnostic and Therapeutic Cardiac Catheterization
Retinal emboli is a common phenomenon in cardiac catheterization. In this study the investigators evaluate the incidence of retinal emboli post diagnostic and therapeutic cardiac catheterization over 300 patients. The incidence was 6.3% and had no clinical sequel on visual acuity and visual field.
Background and Purpose Cardiac catheterization may cause retinal embolization, a risk factor
for cerebrovascular emboli and stroke. We describe the incidence of clinically silent and
apparent retinal emboli following diagnostic and interventional coronary catheterization and
associated risk factors.
Methods Three hundred selected patients attending a tertiary referral center for diagnostic
and therapeutic cardiac catheterization were studied. Direct retinal examination and
examination of the visual field and acuity were done before and after catheterization by a
retinal specialist.
;
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04610463 -
Evaluation of the Severity of Right to Left Shunt in PFO Patients After Systemic Embolism
|
N/A | |
| Completed |
NCT00479362 -
Anticoagulant Therapy During Pacemaker Implantation
|
Phase 4 | |
| Recruiting |
NCT05907564 -
Aventus Thrombectomy System Pulmonary Embolism Clinical Study
|
N/A | |
| Completed |
NCT00781391 -
Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation
|
Phase 3 | |
| Recruiting |
NCT05684146 -
Protect the Head to Head Study
|
Phase 2 | |
| Recruiting |
NCT04263038 -
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
|
Phase 4 | |
| Enrolling by invitation |
NCT04910360 -
Embolism in COVID-19 Positive Patients
|
||
| Recruiting |
NCT01823185 -
Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
|
Phase 4 | |
| Completed |
NCT00453518 -
The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts
|
N/A | |
| Completed |
NCT06018090 -
Microembolic Detection in Acute Ischemic Stroke Patients With Atrial Fibrillation and Outcome
|
||
| Recruiting |
NCT01878539 -
Oral Anticoagulation and Self-management
|
N/A | |
| Completed |
NCT00345618 -
Clinical Study Assessing SSR126517E Injections Once-weekly in Pulmonary Embolism Therapeutic Approach
|
Phase 3 | |
| Recruiting |
NCT04657120 -
Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy
|
N/A | |
| Completed |
NCT01925755 -
Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients
|
N/A | |
| Completed |
NCT00830570 -
The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
|
N/A | |
| Completed |
NCT03714048 -
Blood Management During ECMO for Cardiac Support
|
||
| Not yet recruiting |
NCT06103448 -
Prediction of the Risks of Cardiovascular Mortality
|
||
| Completed |
NCT00509171 -
Effect of a Novel Reamer-Irrigator-Aspirator on the Incidence of Fat Embolism
|
N/A | |
| Recruiting |
NCT06134739 -
Arterial Embolism After Catheter Ablation of Atrial Fibrillation. ATRIAL FIBRILLATION
|
||
| Recruiting |
NCT04436978 -
What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
|
Phase 4 |